# Cartalax dosage guide

> Review Cartalax dosage information by administration route, with source-linked dose and schedule details.

Canonical: https://pepflow.app/peptides/cartalax/dosage/

Review Cartalax capsule amounts, pre-meal timing and standalone courses, separately from sequential multi-product programs.

[Full Cartalax library reference](<https://pepflow.app/peptides/cartalax/>)

## Cartalax dosage chart

This summary table compares available dose amounts and schedules by administration route.

| Route | Dose | Frequency & duration |
| --- | --- | --- |
| Oral | 1–3 capsules | 2–3 times daily · 30–45 days |

## Cartalax dosage by administration route

### Cartalax oral capsules (cartalax) dosage

For the capsule preparation, the specified amount is one to three capsules two to three times daily, 10–15 minutes before meals, for 30–45 days. A separate sequential ten-day program does not define the same standalone course.[\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>)

Cartalax is the Ala-Glu-Asp tripeptide associated with cartilage-cell signaling. Purified AED and cartilage extracts are different preparations.[\[6\]](<https://pepflow.app/peptides/cartalax/dosage/#source-6>) [\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>) [\[1\]](<https://pepflow.app/peptides/cartalax/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/cartalax/dosage/#source-2>)

### Frequency and timing

Capsules are taken 10–15 minutes before meals.[\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>) [\[6\]](<https://pepflow.app/peptides/cartalax/dosage/#source-6>)

### Cycle length and breaks

Oral capsules (Cartalax): 30–45 days. A standard break interval between courses is not established.[\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>)

## Cartalax safety and side effects

### Approval and product quality

Cartalax is not an FDA-approved drug.[\[5\]](<https://pepflow.app/peptides/cartalax/dosage/#source-5>)

### Side effects and long-term safety

Human absorption, repeated-course tolerability, interactions and a side-effect profile have not been established for a characterized oral AED product.[\[1\]](<https://pepflow.app/peptides/cartalax/dosage/#source-1>) [\[6\]](<https://pepflow.app/peptides/cartalax/dosage/#source-6>) [\[4\]](<https://pepflow.app/peptides/cartalax/dosage/#source-4>)

### Route-specific dosing limits

Purified AED and cartilage extracts differ in composition and exposure and cannot be treated as equivalent. An alternative schedule uses 1–5 mg subcutaneously daily for ten days, with an unspecified break measured in months. This reported injection pattern is separate from oral capsule directions; the source also calls Cartalax a tetrapeptide, whereas the canonical AED identity is a tripeptide. Additional schedules attributed to Everything Peptide are reported patterns; citing research does not make these schedules clinically established or approved product instructions.[\[1\]](<https://pepflow.app/peptides/cartalax/dosage/#source-1>) [\[4\]](<https://pepflow.app/peptides/cartalax/dosage/#source-4>)

## Common Cartalax dosage questions

### What dosage is listed for Cartalax?

For the capsule preparation, the specified amount is one to three capsules two to three times daily, 10–15 minutes before meals, for 30–45 days.[\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>)

### When is Cartalax administered?

Capsules are taken 10–15 minutes before meals.[\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>) [\[6\]](<https://pepflow.app/peptides/cartalax/dosage/#source-6>)

### Does Cartalax have a standard cycle or break interval?

Oral capsules (Cartalax): 30–45 days. A standard break interval between courses is not established.[\[7\]](<https://pepflow.app/peptides/cartalax/dosage/#source-7>)

## Sources

- [\[1\] **\[The influence of peptides on the chondrogenic differentiation of human mesenchymal stem cells during replicative aging.\]** Adv Gerontol, 2023. in vitro.](<https://pubmed.ncbi.nlm.nih.gov/37782646/>)
- [\[2\] **\[Peptides prevent the forming of secretory phenotype of chondrocytes associated with the aging.\]** Adv Gerontol, 2023. in vitro.](<https://pubmed.ncbi.nlm.nih.gov/37356100/>)
- [\[3\] **Complex application of peptide bioregulators: developer proposal** Peptide Product, 2021. developer proposal.](<https://peptideproduct.eu/upload/ebook/complex_application_2021_en.pdf>)
- [\[4\] **\[Effect of peptide regulators on the structural and functional status of bone tissue in ageing rats\]** Adv Gerontol, 2007. animal.](<https://pubmed.ncbi.nlm.nih.gov/18306703/>)
- [\[5\] **Search Drugs@FDA for Cartalax** U.S. Food and Drug Administration, Drugs@FDA via OpenFDA. database query.](<https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm>)
- [\[6\] **Peptide Bioregulators: Cytomaxes, Cytogens, and Lingua** Peptide Product. reference catalog.](<https://peptideproduct.eu/upload/ebook/brochure_peptide_bioregulators_EN.pdf>)
- [\[7\] **Clinical research with peptide bioregulators** Peptide Product. reference catalog.](<https://peptideproduct.com/upload/ebook/brochure_clinical_researches_citomaxes_citogens_english.pdf>)

[Full Cartalax library reference →](<https://pepflow.app/peptides/cartalax/>)

## Related

- [Cartalax Peptide](<https://pepflow.app/peptides/cartalax/>)
